Literature DB >> 2510594

In vitro bactericidal activities of gentamicin, cefazolin, and imipenem in peritoneal dialysis fluids.

D C Halstead1, J Guzzo, J A Giardina, A E Geshan.   

Abstract

Continuous ambulatory peritoneal dialysis is an important modality of therapy for patients with renal disease. However, peritonitis continues to be a major risk factor and is usually treated by intraperitoneal administration of antimicrobial agents. Few data are available concerning the stability of antimicrobial agents in peritoneal dialysis solution beyond 48 h. Our investigation was designed to establish the chemical and biological stability of gentamicin alone and in combination with cefazolin in peritoneal dialysis solution at 6 and 72 h by an immunoassay and by an in vitro bactericidal test against American Type Culture Collection (Rockville, Md.) strains of Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis. In addition, uninfected peritoneal dialysis effluent was inoculated with three American Type Culture Collection strains and gentamicin or imipenem. Gentamicin alone or in combination with cefazolin was not altered chemically and was bactericidal for Staphylococcus spp. but not P. aeruginosa. In contrast, imipenem was active against both Staphylococcus spp. and P. aeruginosa. Undefined factors other than inactivation of gentamicin may be responsible for the lack of bactericidal activity and treatment failure of Pseudomonas infections.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2510594      PMCID: PMC172701          DOI: 10.1128/AAC.33.9.1553

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Therapeutic implications of interaction of gentamicin and penicillins.

Authors:  P Noone; J R Pattison
Journal:  Lancet       Date:  1971-09-11       Impact factor: 79.321

2.  Successful treatment of Pseudomonas peritonitis during continuous ambulatory peritoneal dialysis.

Authors:  V Nguyen; R D Swartz; J Reynolds; D Wilson; F K Port
Journal:  Am J Nephrol       Date:  1987       Impact factor: 3.754

Review 3.  Microbiologic aspects of chronic ambulatory peritoneal dialysis.

Authors:  S I Vas
Journal:  Kidney Int       Date:  1983-01       Impact factor: 10.612

4.  Antibiotic activity in peritoneal dialysate.

Authors:  J Rubin; J Humphries; G Smith; J Bower
Journal:  Am J Kidney Dis       Date:  1983-11       Impact factor: 8.860

5.  Stability of gentamicin and cefamandole in serum.

Authors:  S M Teil; L L Arwood; J A Visconti
Journal:  Am J Hosp Pharm       Date:  1982-03

6.  Effect of peritoneal dialysis solution on the antimicrobial activity of cephalosporins.

Authors:  D H Appleby; J F John
Journal:  Nephron       Date:  1982       Impact factor: 2.847

7.  Analysis of continuous ambulatory peritoneal dialysis-related Pseudomonas aeruginosa infections.

Authors:  J Bernardini; B Piraino; M Sorkin
Journal:  Am J Med       Date:  1987-11       Impact factor: 4.965

8.  Comparative aminoglycoside inactivation by beta-lactam antibiotics. Effects of a cephalosporin and six penicillins on five aminoglycosides.

Authors:  L J Riff; J L Thomason
Journal:  J Antibiot (Tokyo)       Date:  1982-07       Impact factor: 2.649

9.  Pseudomonas peritonitis and continuous ambulatory peritoneal dialysis.

Authors:  R Krothapalli; W B Duffy; C Lacke; W Payne; H Patel; V Perez; H O Senekjian
Journal:  Arch Intern Med       Date:  1982-10

10.  Continuous ambulatory peritoneal dialysis.

Authors:  R P Popovich; J W Moncrief; K D Nolph; A J Ghods; Z J Twardowski; W K Pyle
Journal:  Ann Intern Med       Date:  1978-04       Impact factor: 25.391

View more
  3 in total

1.  Cephazolin and gentamicin are stable in lactate-buffered fresenius peritoneal dialysate for seven days at room temperature.

Authors:  Gillian K Balbir Singh; Martin J Wolley; Valmai C Laycock; David M Voss; Martin J Middleditch; Mark R Marshall
Journal:  Perit Dial Int       Date:  2014 Mar-Apr       Impact factor: 1.756

2.  Influence of carbon dioxide on growth and antibiotic susceptibility of coagulase-negative staphylococci cultured in human peritoneal dialysate.

Authors:  M H Wilcox; D G Smith; J A Evans; S P Denyer; R G Finch; P Williams
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

3.  Peritoneal fluid titer test for peritoneal dialysis-related peritonitis.

Authors:  Christine Strijack; Godfrey K M Harding; Robert E Ariano; Sheryl A Zelenitsky
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.